Apoptosis in cancer: from pathogenesis to treatment

被引:2173
作者
Wong, Rebecca S. Y. [1 ]
机构
[1] Int Med Univ, Sch Med & Hlth Sci, Div Human Biol, Kuala Lumpur 57000, Malaysia
关键词
Apoptosis; defective apoptotic pathways; carcinogenesis; treatment target; CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 FAMILY PROTEINS; CELLS IN-VITRO; PANCREATIC-CANCER; DOWN-REGULATION; BREAST-CANCER; LUNG-CANCER; HEMATOLOGIC MALIGNANCIES; THERAPEUTIC TARGETS; COLORECTAL-CANCER;
D O I
10.1186/1756-9966-30-87
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions. It is also one of the most studied topics among cell biologists. An understanding of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases. In some, the problem is due to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the culprit. Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die. The mechanism of apoptosis is complex and involves many pathways. Defects can occur at any point along these pathways, leading to malignant transformation of the affected cells, tumour metastasis and resistance to anticancer drugs. Despite being the cause of problem, apoptosis plays an important role in the treatment of cancer as it is a popular target of many treatment strategies. The abundance of literature suggests that targeting apoptosis in cancer is feasible. However, many troubling questions arise with the use of new drugs or treatment strategies that are designed to enhance apoptosis and critical tests must be passed before they can be used safely in human subjects.
引用
收藏
页数:14
相关论文
共 104 条
[1]  
Abou-Nassar Karim, 2010, Clin Adv Hematol Oncol, V8, P886
[2]   Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA [J].
Albershardt, Tina C. ;
Salerni, Bethany L. ;
Soderquist, Ryan S. ;
Bates, Darcy J. P. ;
Pletnev, Alexandre A. ;
Kisselev, Alexei F. ;
Eastman, Alan .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (28) :24882-24895
[3]  
[Anonymous], 2008, CELL MOL BIOL CONCEP
[4]   Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern [J].
Ashhab, Y ;
Alian, A ;
Polliack, A ;
Panet, A ;
Ben Yehuda, D .
FEBS LETTERS, 2001, 495 (1-2) :56-60
[5]   P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation [J].
Avery-Kiejda, Kelly A. ;
Bowden, Nikola A. ;
Croft, Amanda J. ;
Scurr, Lyndee L. ;
Kairupan, Carla F. ;
Ashton, Katie A. ;
Talseth-Palmer, Bente A. ;
Rizos, Helen ;
Zhang, Xu D. ;
Scott, Rodney J. ;
Hersey, Peter .
BMC CANCER, 2011, 11
[6]  
BAI L., 2006, J CANC MOL, V2, P141
[7]   The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: Role in sensitization to TRAIL apoptosis [J].
Baritaki, Stavroula ;
Militello, Loredana ;
Malaponte, Graziella ;
Spandidos, Demetrios A. ;
Salcedo, Margarita ;
Bonavida, Benjamin .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (06) :1683-1694
[8]   New tricks of an old molecule: lifespan regulation by p53 [J].
Bauer, Johannes H. ;
Helfand, Stephen L. .
AGING CELL, 2006, 5 (05) :437-440
[9]   Targeted rescue of a destabilized mutant of p53 by an in silico screened drug [J].
Boeckler, Frank M. ;
Joerger, Andreas C. ;
Jaggi, Gaurav ;
Rutherford, Trevor J. ;
Veprintsev, Dmitry B. ;
Fersht, Alan R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (30) :10360-10365
[10]   Gene transfer of constitutively active caspase-3 induces apoptosis in a human hepatoma cell line [J].
Cam, L ;
Boucquey, A ;
Coulomb-L'hermine, A ;
Weber, A ;
Horellou, P .
JOURNAL OF GENE MEDICINE, 2005, 7 (01) :30-38